Paloma Partners’s BioAtla BCAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-1,944
Closed -$133K 1170
2024
Q2
$133K Buy
+1,944
New +$231K ﹤0.01% 1044

Other funds holding BCAB

Paloma Partners's BCAB Position: Q3 2024 in Review

Paloma Partners sold out of BioAtla (BCAB) in Q3 2024, closing a stake of 1,944 shares — an estimated $133K sold.

Paloma Partners first reported a position in BCAB in Q2 2024 and held it in 1 quarter. The position peaked at $133K in Q2 2024. 63 funds tracked by Wall St. Rank hold BCAB as of Q3 2024.

  • Paloma Partners reported no remaining BioAtla position as of Q3 2024 after selling out during the quarter.
  • Paloma Partners sold 1,944 BioAtla shares in Q3 2024, an estimated $133K.
  • Paloma Partners first reported a position in BioAtla in Q2 2024 and held it in 1 quarter.
  • Paloma Partners's BioAtla position peaked at $133K in Q2 2024.
  • 63 funds tracked by Wall St. Rank held BioAtla as of Q3 2024.

Based on Paloma Partners's 13F filing for Q3 2024, filed 14 Nov 2024.